rs2074714

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_014141.6(CNTNAP2):​c.1897+89A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.658 in 1,539,444 control chromosomes in the GnomAD database, including 334,600 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.68 ( 34895 hom., cov: 33)
Exomes 𝑓: 0.66 ( 299705 hom. )

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.57

Publications

9 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 7-147562346-A-G is Benign according to our data. Variant chr7-147562346-A-G is described in ClinVar as Benign. ClinVar VariationId is 670633.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.722 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTNAP2NM_014141.6 linkc.1897+89A>G intron_variant Intron 12 of 23 ENST00000361727.8 NP_054860.1 Q9UHC6-1A0A090N7T7B2RCH4
CNTNAP2XM_017011950.3 linkc.1897+89A>G intron_variant Intron 12 of 13 XP_016867439.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTNAP2ENST00000361727.8 linkc.1897+89A>G intron_variant Intron 12 of 23 1 NM_014141.6 ENSP00000354778.3 Q9UHC6-1
CNTNAP2ENST00000636870.1 linkn.1759+89A>G intron_variant Intron 10 of 21 5
CNTNAP2ENST00000637825.1 linkn.1380+89A>G intron_variant Intron 9 of 13 5
CNTNAP2ENST00000638117.1 linkn.1800+89A>G intron_variant Intron 11 of 12 5

Frequencies

GnomAD3 genomes
AF:
0.675
AC:
102669
AN:
151992
Hom.:
34852
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.729
Gnomad AMI
AF:
0.712
Gnomad AMR
AF:
0.718
Gnomad ASJ
AF:
0.618
Gnomad EAS
AF:
0.626
Gnomad SAS
AF:
0.630
Gnomad FIN
AF:
0.594
Gnomad MID
AF:
0.636
Gnomad NFE
AF:
0.656
Gnomad OTH
AF:
0.673
GnomAD4 exome
AF:
0.656
AC:
910184
AN:
1387334
Hom.:
299705
AF XY:
0.653
AC XY:
453692
AN XY:
694412
show subpopulations
African (AFR)
AF:
0.730
AC:
23288
AN:
31900
American (AMR)
AF:
0.726
AC:
32243
AN:
44430
Ashkenazi Jewish (ASJ)
AF:
0.633
AC:
16210
AN:
25616
East Asian (EAS)
AF:
0.609
AC:
23860
AN:
39160
South Asian (SAS)
AF:
0.620
AC:
52113
AN:
84114
European-Finnish (FIN)
AF:
0.611
AC:
30391
AN:
49778
Middle Eastern (MID)
AF:
0.630
AC:
2552
AN:
4048
European-Non Finnish (NFE)
AF:
0.658
AC:
691274
AN:
1050430
Other (OTH)
AF:
0.661
AC:
38253
AN:
57858
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
14803
29607
44410
59214
74017
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17754
35508
53262
71016
88770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.676
AC:
102765
AN:
152110
Hom.:
34895
Cov.:
33
AF XY:
0.671
AC XY:
49852
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.729
AC:
30251
AN:
41500
American (AMR)
AF:
0.718
AC:
10975
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.618
AC:
2147
AN:
3472
East Asian (EAS)
AF:
0.626
AC:
3237
AN:
5168
South Asian (SAS)
AF:
0.630
AC:
3038
AN:
4822
European-Finnish (FIN)
AF:
0.594
AC:
6266
AN:
10556
Middle Eastern (MID)
AF:
0.619
AC:
182
AN:
294
European-Non Finnish (NFE)
AF:
0.656
AC:
44599
AN:
67986
Other (OTH)
AF:
0.673
AC:
1421
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1755
3511
5266
7022
8777
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
810
1620
2430
3240
4050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.669
Hom.:
5802
Bravo
AF:
0.688
Asia WGS
AF:
0.637
AC:
2218
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.46
DANN
Benign
0.53
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2074714; hg19: chr7-147259438; COSMIC: COSV62146583; API